HR Execs on the Move


 
Natera Inc. is a genetic testing company that specializes in analyzing tiny quantities of DNA for reproductive health. Natera operates a CLIA-certified laboratory in San Carlos, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include pre-implantation genetic diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos generated during an IVF cycle; products-of-conception testing following miscarriage to analyze fetal chromosomes and understand the cause of the pregnancy loss; non-invasive prenatal testing to determine paternity; carrier screening to detect whether parents carry genetic variations that may result in disease in the child; and Panorama, a ...
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.natera.com
  • 201 Industrial Rd
    San Carlos, CA USA 94070
  • Phone: 650.249.9090

Executives

Name Title Contact Details
Chris Deppmeier
Director, Corporate Marketing Profile
Robert Booth
Co-Founder and Chief Revenue Officer Profile
Karen Fitch
Director, RandD Profile
Marlea Gemmel
Associate Director, Clinical Genomics RandD Profile
Maxim Brevnov
Senior VP R&D - Molecular Development Profile

Similar Companies

Shonar Bangla

Shonar Bangla is a Greenbelt, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Colonial Dental Laboratory Inc

Colonial Dental Laboratory Inc is a West Berlin, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Therion International

Therion International is a Saratoga Springs, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Agendia USA

Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free.

Artisan Dental Laboratories

Artisan Dental Laboratories is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.